Eur Rev Med Pharmacol Sci 2023; 27 (1): 2-2
DOI: 10.26355/eurrev_202301_30845

Author Correction: Experimental study on thioredoxin redox inhibitor 1-methylpropyl 2-imidazolyl disulfide promoting apoptosis of multiple myeloma cells in vitro and in vivo

Q.-D. Lin, L.-N. Liu, X.-Y. Liu, Y. Yan, B.-J. Fang, Y.-L. Zhang, J. Zhou, Y.-F. Li, W.-L. Zuo, Y.-P. Song

Henan Key Lab of Experimental Hematology, Henan Institute of Hematology, Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China


Correction to: European Review for Medical and Pharmacological Sciences 2022; 26 (4): 1283-1292. DOI: 10.26355/eurrev_202202_28121-PMID: 35253185-published online on December 15, 2022.

After publication, the authors corrected the order of the author’s affiliations as follows:

Q.-D. Lin1,2,3,4, L.-N. Liu1,2,3,4, X.-Y. Liu1,2, Y. Yan1,2, B.-J. Fang1,2,3,4, Y.-L. Zhang1,2,3,4, J. Zhou1,2,3,4, Y.-F. Li1,2,3,4, W.-L. Zuo1,2,3,4, Y.-P. Song1,2,3,4

1Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou City, Henan Province, China

2Henan Cancer Hospital, Zhengzhou City, Henan Province, China

3Henan Key Lab of Experimental Hematology, Zhengzhou City, Henan Province, China

4Henan Institute of Hematology, Zhengzhou City, Henan Province, China

 

There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause.

Experimental study on thioredoxin redox inhibitor 1-methylpropyl 2-imidazolyl disulfide promoting apoptosis of multiple myeloma cells in vitro and in vivo

 

Free PDF Download

To cite this article

Q.-D. Lin, L.-N. Liu, X.-Y. Liu, Y. Yan, B.-J. Fang, Y.-L. Zhang, J. Zhou, Y.-F. Li, W.-L. Zuo, Y.-P. Song
Author Correction: Experimental study on thioredoxin redox inhibitor 1-methylpropyl 2-imidazolyl disulfide promoting apoptosis of multiple myeloma cells in vitro and in vivo

Eur Rev Med Pharmacol Sci
Year: 2023
Vol. 27 - N. 1
Pages: 2-2
DOI: 10.26355/eurrev_202301_30845